• Contact quintiles

    Phone:+1 866 267 4479

    Request a Proposal

  • London - Phase I Clinical Trial Facility

    Quintiles’ Phase I facility in London has been running Phase I/IIa trials for more than 25 years. Here, we have conducted first-in-human studies with hundreds of new molecules with an unsurpassed safety record.

    Located in the heart of the city, Quintiles Drug Research Unit is spread over two sites: in Guy’s Hospital Tower and at Newcomen Street, inside Guy’s campus. We have established close collaborations with university research groups. The most recent, a formal partnership with King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, will focus on translational medicine. A dedicated team of clinical physiologists are continuously developing new biomarkers and techniques for Phase I/Phase IIa studies.

    Our unit has specialized facilities for:

    • Respiratory studies 
    • EEG studies 
    • Sleep studies 
    • Viral challenge studies 
    • Human radio-labeled ADME studies 

    Clinic Features

    • 55 hospital beds
    • Connected to Quintiles’ custom Phase I Clinical Trial System for electronic data capture (Part 11 compliant)
    • Continuous cardiac monitoring/wireless telemetry and emergency crash carts on each ward
    • Full-time specialists include principal investigators, clinical physiologists, clinical research nurses, pharmacists, clinical project managers, data managers and other support staff
    • Onsite pharmacy holds GMP manufacturing authorization
    • Volunteer amenities include spacious recreation areas and wireless internet

    Therapeutic areas

    Cardiovascular, central nervous system, metabolic, respiratory & inflammation, urology & gastroenterology, and vaccines & infectious diseases